ELK1 and osteosarcoma: Taken together, significant evidence exists suggesting that ELK1 is able to promote the chemoresistance of osteosarcoma cells to DXR by promoting aerobic glycolysis and cell viability of osteosarcoma cells via upregulation of miR-134-targeted PTBP1.